glp-1 impact on bariatric surgery vs Medications for Long-Term Weight Loss Bariatric surgeries on the decline

With the introduction of ART, the estimated prevalence of NeuroHIV is approximately 42.6%

Saande CJ, Webb JL, Curry PE, Rowling MJ, Schalinske KL

Effect of saffron versus selective serotonin reuptake inhibitors (SSRIs) in treatment of depression and anxiety: A meta-analysis of randomized controlled trials

doi:10.1111/jdv.13752

Reduces pain in joints and injured muscle tissue Treatment of intestinal and digestive system-related disorders Improves digestive functions and protects the stomach lining, including against long-term medication regimens like NSAIDs

In the series of 11 clinical trials (SUSTAIN programme) GLP-1 agonists demonstrated improved glycemic control in patients with diabetes (as measured by HbA1c) but also showed a consistent weight loss in trial participants